Ionis Pharmaceuticals Financials - Benzinga

Ionis Pharmaceuticals Inc

IONSNASDAQ

Trade with Public

Trade with Public

$60.66

-0.39-0.64%

Last update: Aug 31, 9:30 AM

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Ionis Pharmaceuticals Financials

Ionis Pharmaceuticals (IONS) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Alnylam Lowers 2026 Outlook As Second-Line Amvuttra Demand Normalizes, Stock Tanks

Alnylam cut its 2026 sales outlook despite a Q2 earnings beat as slower ATTR-CM market growth weighed on expectations and investors reacted.

Vandana Singh

Biogen Boosts Profit Forecast with Growth Across Alzheimer's, Rare Disease Portfolio

Biogen beat second-quarter earnings and revenue estimates, raised its 2026 guidance, and reported pipeline progress.

Vandana Singh

PRO
Ionis Pharmaceuticals Affirms FY2026 Sales Guidance of $875.000M-$900.000M vs $895.148M Est

Ionis Pharmaceuticals (NASDAQ:IONS) affirms FY2026 sales outlook from $875.000 million-$900.000 million to $875.000 million-$900.000 million vs $895.148 million estimate.

Benzinga Newsdesk

PRO
Ionis Pharmaceuticals Q2 Adj. EPS $(0.42) Beats $(1.07) Estimate, Sales $268.000M Beat $190.670M Estimate

Ionis Pharmaceuticals (NASDAQ:IONS) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $(1.07) by 60.75 percent. This is a 149.41 percent decrease over earnings of $0.85 per

Benzinga Newsdesk

PRO
Ionis Pharmaceuticals Affirms FY2026 Sales Guidance of $875.000M-$900.000M vs $893.928M Est

Ionis Pharmaceuticals (NASDAQ:IONS) affirms FY2026 sales outlook from $875.000 million-$900.000 million to $875.000 million-$900.000 million vs $893.928 million estimate.

Benzinga Newsdesk

Stock Market Today: S&P 500, Nasdaq 100, Dow Jones Futures Rise as US-Iran Exchange Strikes—Levi Strauss, AZZ, Ionis Pharma In Focus (UPDATED)

U.S. stock futures advanced on Thursday, as the Dow Jones, Nasdaq 100, and S&P 500 indices rose, following Wednesday's mixed close.

Rishabh Mishra